202 related articles for article (PubMed ID: 21335481)
1. Adenosine receptor-mediated cardioprotection: are all 4 subtypes required or redundant?
McIntosh VJ; Lasley RD
J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):21-33. PubMed ID: 21335481
[TBL] [Abstract][Full Text] [Related]
2. Adenosine A₂A and A₂B receptors are both required for adenosine A₁ receptor-mediated cardioprotection.
Zhan E; McIntosh VJ; Lasley RD
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H1183-9. PubMed ID: 21743001
[TBL] [Abstract][Full Text] [Related]
3. Adenosine receptors and reperfusion injury of the heart.
Headrick JP; Lasley RD
Handb Exp Pharmacol; 2009; (193):189-214. PubMed ID: 19639283
[TBL] [Abstract][Full Text] [Related]
4. Both A2a and A2b adenosine receptors at reperfusion are necessary to reduce infarct size in mouse hearts.
Methner C; Schmidt K; Cohen MV; Downey JM; Krieg T
Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1262-4. PubMed ID: 20709859
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of adenosine A2a and A2b receptors on cardiac contractility.
Chandrasekera PC; McIntosh VJ; Cao FX; Lasley RD
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H2082-9. PubMed ID: 20935155
[TBL] [Abstract][Full Text] [Related]
6. Effects of targeted deletion of A1 adenosine receptors on postischemic cardiac function and expression of adenosine receptor subtypes.
Morrison RR; Teng B; Oldenburg PJ; Katwa LC; Schnermann JB; Mustafa SJ
Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1875-82. PubMed ID: 16679400
[TBL] [Abstract][Full Text] [Related]
7. Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor.
Kreckler LM; Wan TC; Ge ZD; Auchampach JA
J Pharmacol Exp Ther; 2006 Apr; 317(1):172-80. PubMed ID: 16339914
[TBL] [Abstract][Full Text] [Related]
8. Cooperative cardioprotection through adenosine A1 and A2A receptor agonism in ischemia-reperfused isolated mouse heart.
Urmaliya VB; Pouton CW; Ledent C; Short JL; White PJ
J Cardiovasc Pharmacol; 2010 Oct; 56(4):379-88. PubMed ID: 20930592
[TBL] [Abstract][Full Text] [Related]
9. Semi-rational design of (north)-methanocarba nucleosides as dual acting A(1) and A(3) adenosine receptor agonists: novel prototypes for cardioprotection.
Jacobson KA; Gao ZG; Tchilibon S; Duong HT; Joshi BV; Sonin D; Liang BT
J Med Chem; 2005 Dec; 48(26):8103-7. PubMed ID: 16366590
[TBL] [Abstract][Full Text] [Related]
10. A1 adenosine receptor negatively modulates coronary reactive hyperemia via counteracting A2A-mediated H2O2 production and KATP opening in isolated mouse hearts.
Zhou X; Teng B; Tilley S; Mustafa SJ
Am J Physiol Heart Circ Physiol; 2013 Dec; 305(11):H1668-79. PubMed ID: 24043252
[TBL] [Abstract][Full Text] [Related]
11. The A3 adenosine receptor agonist CP-532,903 [N6-(2,5-dichlorobenzyl)-3'-aminoadenosine-5'-N-methylcarboxamide] protects against myocardial ischemia/reperfusion injury via the sarcolemmal ATP-sensitive potassium channel.
Wan TC; Ge ZD; Tampo A; Mio Y; Bienengraeber MW; Tracey WR; Gross GJ; Kwok WM; Auchampach JA
J Pharmacol Exp Ther; 2008 Jan; 324(1):234-43. PubMed ID: 17906066
[TBL] [Abstract][Full Text] [Related]
12. Adenosine triggers preconditioning through MEK/ERK1/2 signalling pathway during hypoxia/reoxygenation in neonatal rat cardiomyocytes.
Germack R; Dickenson JM
J Mol Cell Cardiol; 2005 Sep; 39(3):429-42. PubMed ID: 16005018
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors.
Eckle T; Krahn T; Grenz A; Köhler D; Mittelbronn M; Ledent C; Jacobson MA; Osswald H; Thompson LF; Unertl K; Eltzschig HK
Circulation; 2007 Mar; 115(12):1581-90. PubMed ID: 17353435
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylinositol 3-kinase and ERK1/2 are not involved in adenosine A1, A2A or A3 receptor-mediated preconditioning in rat ventricle strips.
Button L; Mireylees SE; Germack R; Dickenson JM
Exp Physiol; 2005 Sep; 90(5):747-54. PubMed ID: 15964902
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of the adenosine A3 receptor, not the A1 or A2 receptors, promote neurite outgrowth of retinal ganglion cells.
Nakashima KI; Iwao K; Inoue T; Haga A; Tsutsumi T; Mochita MI; Fujimoto T; Tanihara H
Exp Eye Res; 2018 May; 170():160-168. PubMed ID: 29486164
[TBL] [Abstract][Full Text] [Related]
16. Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injury.
Gazoni LM; Walters DM; Unger EB; Linden J; Kron IL; Laubach VE
J Thorac Cardiovasc Surg; 2010 Aug; 140(2):440-6. PubMed ID: 20398911
[TBL] [Abstract][Full Text] [Related]
17. Anesthetic cardioprotection: the role of adenosine.
Bonney S; Hughes K; Eckle T
Curr Pharm Des; 2014; 20(36):5690-5. PubMed ID: 24502579
[TBL] [Abstract][Full Text] [Related]
18. A(3) adenosine receptor: a plausible therapeutic target for cardio-protection in diabetes.
Nishat S; Shabir H; Azmi AS; Ansari HR
Recent Pat Cardiovasc Drug Discov; 2012 Apr; 7(1):59-70. PubMed ID: 22300387
[TBL] [Abstract][Full Text] [Related]
19. Role of direct RhoA-phospholipase D1 interaction in mediating adenosine-induced protection from cardiac ischemia.
Mozzicato S; Joshi BV; Jacobson KA; Liang BT
FASEB J; 2004 Feb; 18(2):406-8. PubMed ID: 14688204
[TBL] [Abstract][Full Text] [Related]
20. Physiology and effects of nucleosides in mice lacking all four adenosine receptors.
Xiao C; Liu N; Jacobson KA; Gavrilova O; Reitman ML
PLoS Biol; 2019 Mar; 17(3):e3000161. PubMed ID: 30822301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
